Allan Flyvbjerg

CEO, clinical professor,
SDCC Senior Management Team

Portrait photo of Allan FlyvbjergContact

Phone: +45 51 77 95 48


Research area

Pre-clinical and clinical research in the pathogenesis, prevention and treatment of diabetic micro- and macrovascular complications in type 1- and type 2-diabetes.

The purpose of the research is to combat the development of late complications in diabetes. Further, to develop new biomarkers and treatment modalities of vascular complications to diabetes.    

Current research


Responsible editor